Abstracts

Abstracts

Abstract Submission for the 2026 NF Conference

Abstract Submissions are now open. Researchers, clinicians, and scientists are invited to share their latest findings with the NF community.

All NF-relevant abstracts are welcome; however, those aligned with the themes for the 2026 conference will receive a prioritized review. Themes include:

  • Developmental Origins and Cellular Drivers of NF
  • Altered Metabolism in NF
  • Tumor Immunology and Immunotherapy: From Antigens to Adoptive Cell Therapy
  • NextGen Translational Pipelines: From Models to Clinical Impact
  • Pain
  • Neurocognition

All submitted abstracts will be reviewed by a minimum of three members of a scientific committee. Reviewers will score abstracts according to their scientific and/or clinical value, relevance to the NF Conference, and impact on the field of NF.

Abstract will be considered for Platform Presentations, Poster Presentations, and Publication Only.

An abstract acceptance for Platform or Poster requires an in-person presentation at the 2026 NF Conference in Denver, Colorado. Authors unable to travel may designate a co-author or member of their scientific team to present on their behalf. Presenters are required to register for the NF Conference to make their Platform or Poster presentation.

Submit Abstract


Submission Timeline

  • March 2, 2026: Abstract Submission Deadline
  • March 2-31, 2026: Abstract Review Period
  • April 1, 2026: Acceptance/Rejection Notices Sent
  • June 14, 2026: Submission Deadline for Platform Presentation Materials
  • June 15-24, 2026: Material Review Process
  • June 26-30, 2026: See you in Denver!

Link to 2026 Resource Guide